Houston man gets 4 years in federal prison for running Houston, Dallas pill mills

1 Houston

Houston News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search


A Houston man was sentenced Friday to more than four years in federal prison for his role in running pill mills that obtained oxycodone pain medication through clinics in the Houston, Dallas and Channelview.

Fahim Ahmed Khan, 59, was also ordered to pay a $17,500 fine by U.S. District Judge Sidney A. Fitzwater in Dallas.

Khan, who pleaded guilty to one count of conspiracy in August, was among more than two dozen people indicted in the Northern District of Texas, accused of obtaining prescriptions by luring phony patients – often homeless people – to the clinics.

He collected $420 to $600 in cash from each patient who obtained a prescription for oxycodone, and the pills were then resold, according to federal court documents outlining Khan’s guilty plea.

The prescription ring operated from January 2013 to at least July 29, 2014, according to federal documents. Khan established relationships with medical professionals and clinic owners – among those, Muhammad Faridi and Dr. Richard Andrews of the McAllen Medical Clinic in Dallas, who were described by federal officials as co-conspirators.

Khan also developed relationships at TIG Healthcare and Diagnostic Clinic on Harwin Drive in Houston and the ABS Medical and Chiropractic Clinic in Channelview, according to court documents filed in conjunction with his guilty plea.

Khan remains free on bond but has been ordered to begin his sentence on Sept. 5.  His attorney, Mark Bennett, declined to comment on the case.

Altogether, 26 people have been convicted in the scheme, according to a press release from U.S. Attorney John R. Parker in Dallas.

Khan was never a licensed medical practitioner and he never obtained a registration number from the U.S. Drug Enforcement Administration.


1 Houston

Houston News & Search

1 News - 1 eMovies - 1 eMusic - 1 eBooks - 1 Search


Facebooktwitterredditpinterestlinkedinmail

Facebooktwitterlinkedinrssyoutube

Leave a Reply